Caplin Point Laboratories Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
10217.96 Cr.
|
P/BV
|
5.43
|
Book Value (Rs.)
|
247.62
|
52 Week High/Low (Rs.)
|
1619/658
|
FV/ML
|
2/1
|
P/E(X)
|
27.16
|
Bookclosure
|
21/09/2023
|
EPS (Rs.)
|
49.55
|
Div Yield (%)
|
0.33
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 451.35 | 385.82 | 313.62 | 269.46 | 226.88 |
| | | | | |
Net CashFlow From Operating Activities | 271.37 | 336.75 | 265.77 | 44.68 | 83.42 |
Net Cash Used In Investing Activities | -217.58 | -270.94 | -5.36 | -54.50 | -100.46 |
Net Cash Used From Financing Activities | -28.17 | -40.71 | -23.98 | 79.77 | 89.79 |
Foreign Exchange Gains / Losses | 1.18 | -0.09 | -0.24 | 0.17 | 0.72 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 26.80 | 25.01 | 236.20 | 70.11 | 73.48 |
Cash And Cash Equivalents Begin of Year | 150.76 | 435.72 | 220.77 | 150.65 | 77.17 |
Cash And Cash Equivalents End Of Year | 177.56 | 460.73 | 456.96 | 220.77 | 150.65 |